You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》瑞信首予錦欣生殖(01951.HK)「跑贏大市」評級目標價12.25元
阿思達克 08-06 10:15

瑞信發表研究報告,首予錦欣生殖(01951.HK)「跑贏大市」評級,相信其輔助生殖服務將會在中國越來越受歡迎,因政府擔心人口老化及晚婚問題,以及可支配收入增加,而目前有關項目仍在發展階段有巨大潛力,而且入門門檻高,行業競爭者有限。該行給予公司12.25元目標價。

該行估計潛在的中國輔助生殖服務市場規模約294億美元,是去年實際市場規模38億美元約8倍,在生育率不足,以及可負擔的情況增加下,相信輔助生殖服務可受惠。

該行又指,公司在輔助生殖服務是有穩健表現的企業,在四川的市佔率達50%,加上公司收購深圳中山泌尿外科醫院,及開拓海外市場,相信有助公司可通過併購建立自己的全球領導地位。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account